热门资讯> 正文
RedHill Bizerma计划实施ADS比率变更
2024-08-16 22:23
- RedHill Biopharma (NASDAQ:RDHL) plans to implement a ratio change of the Co.'s ADSs to its non-traded ordinary shares from the current ratio of 1 ADS representing 400 ordinary shares to a new ratio of 1 ADS representing 10,000 ordinary shares.
- The anticipated first date of the ratio change is on or about August 20, 2024, and the Co.'s ADSs will continue to be traded on the Nasdaq under the symbol "RDHL" with a new CUSIP Number 757468301.
- For ADS holders, the ratio change will have the same effect as a one-for-25 reverse ADS split.
More on RedHill
- Financial information for RedHill
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
